RIEDEL NORBERT G
Insider CIK 1161662 · BAX Corporate Vice President · JAZZ Director · APTX EXECUTIVE CHAIRMAN OF THE BOD, Director · ETON Director · CERE Director · ARIA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,692 | $241.39 | $408.4K | 6,923 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 14 | $244.64 | $3.4K | 8,615 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,692 | $241.39 | $408.4K | 6,923 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 14 | $244.64 | $3.4K | 8,615 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 8,629 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 8,629 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-04-21 | 2026-04-22 | 12,500 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-04-21 | 2026-04-22 | 19,655 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-04-21 | 2026-04-22 | 12,500 | $7.31 | $91.4K | 47,500 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-04-21 | 2026-04-22 | 19,655 | $8.61 | $169.2K | 67,155 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise deriv | 2026-02-27 | 2026-03-02 | 3,415 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2026-02-27 | 2026-03-02 | 3,415 | $192.00 | $655.7K | 7,024 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise | 2026-02-27 | 2026-03-02 | 3,415 | $138.08 | $471.5K | 10,439 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | X Exercise deriv | 2026-02-03 | 2026-02-05 | 30,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | X Exercise | 2026-02-03 | 2026-02-05 | 30,000 | $4.42 | $132.6K | 35,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 7,757 | — | $0 | 294,253 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 12,196 | — | $0 | 286,496 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2025-08-08 | 2025-08-11 | 1,805 | $111.25 | $200.8K | 7,024 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2025-08-07 | 2025-08-11 | 3,507 | — | $0 | 8,829 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-03 | 2025-01-06 | 25,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-03 | 2025-01-06 | 50,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-03 | 2025-01-06 | 27,400 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2025-01-03 | 2025-01-06 | 50,000 | $3.78 | $189.0K | 137,145 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2025-01-03 | 2025-01-06 | 27,400 | $3.58 | $98.1K | 87,145 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2025-01-03 | 2025-01-06 | 25,000 | $3.47 | $86.8K | 162,145 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2024-08-06 | 2024-08-06 | 1,484 | $111.35 | $165.2K | 5,322 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2024-08-02 | 2024-08-06 | 3,731 | — | $0 | 6,806 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 95,242 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 10,461 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 46,092 | — | $0 | 10,461 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2024-06-05 | 2024-06-07 | 10,461 | — | $0 | 56,553 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 30,000 | — | $0 | 164,555 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2023-08-14 | 2023-08-15 | 1,241 | $138.16 | $171.5K | 13,705 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2023-08-11 | 2023-08-15 | 3,075 | — | $0 | 14,946 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-07 | 2023-06-09 | 13,780 | — | $0 | 13,780 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2023-06-07 | 2023-06-09 | 3,282 | — | $0 | 46,092 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2023-03-03 | 2023-03-03 | 25,000 | — | $0 | 134,555 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 420,000 | — | $0 | 420,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2022-08-08 | 2022-08-09 | 1,089 | $152.32 | $165.9K | 11,871 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise deriv | 2022-08-05 | 2022-08-09 | 8,000 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2022-08-05 | 2022-08-09 | 8,000 | $155.87 | $1.25M | 10,399 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2022-08-05 | 2022-08-09 | 2,561 | — | $0 | 12,960 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise | 2022-08-05 | 2022-08-09 | 8,000 | $55.28 | $442.2K | 18,399 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-06-14 | 2022-06-16 | 23,459 | — | $0 | 23,459 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2022-02-07 | 2022-02-28 | 50,000 | — | $0 | 109,555 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-01-04 | 2022-01-06 | 14,270 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-01-04 | 2022-01-06 | 14,270 | — | $0 | 42,810 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2021-12-06 | 2021-12-08 | 100,000 | $2.23 | $223.0K | 100,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-12-02 | 2021-12-07 | 475,000 | — | $0 | 475,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2021-08-06 | 2021-08-10 | 1,306 | $147.96 | $193.2K | 10,399 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2021-07-29 | 2021-08-02 | 2,246 | — | $0 | 11,705 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-06-10 | 2021-06-14 | 58,003 | — | $0 | 58,003 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise deriv | 2021-05-17 | 2021-05-19 | 380,000 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise deriv | 2021-05-17 | 2021-05-20 | 380,000 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | F Tax w/h | 2021-05-17 | 2021-05-19 | 127,274 | $2.53 | $322.0K | 615,265 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise | 2021-05-17 | 2021-05-19 | 380,000 | — | $0 | 742,539 | SEC↗ |
| APTX Aptinyx Inc. | F Tax w/h | 2021-05-17 | 2021-05-20 | 127,274 | $2.53 | $322.0K | 615,265 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise | 2021-05-17 | 2021-05-20 | 380,000 | — | $0 | 742,539 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 19,655 | — | $0 | 59,555 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 733,300 | — | $0 | 733,300 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2021-01-04 | 2021-01-06 | 14,270 | — | $0 | 14,270 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2021-01-04 | 2021-01-06 | 14,270 | — | $0 | 28,540 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2020-08-07 | 2020-08-10 | 931 | $125.87 | $117.2K | 9,459 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2020-08-06 | 2020-08-10 | 6,765 | — | $0 | 6,765 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2020-08-06 | 2020-08-10 | 2,705 | — | $0 | 10,390 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2020-03-12 | 2020-03-16 | 27,400 | — | $0 | 27,400 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-02-26 | 2020-02-28 | 625,000 | — | $0 | 625,000 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2020-01-10 | 2020-01-14 | 35,000 | $3.00 | $105.0K | 35,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2019-08-09 | 2019-08-12 | 726 | $135.65 | $98.5K | 7,685 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2019-08-08 | 2019-08-12 | 4,805 | — | $0 | 4,805 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2019-08-08 | 2019-08-12 | 1,920 | — | $0 | 8,411 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-05-16 | 2019-05-17 | 380,000 | — | $0 | 380,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2019-02-20 | 2019-03-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-01-04 | 2019-01-07 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2018-11-15 | 2018-11-15 | 5,000 | $6.00 | $30.0K | 59,745 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise deriv | 2018-11-12 | 2018-11-14 | 38,563 | — | $0 | 441,615 | SEC↗ |
| APTX Aptinyx Inc. | M Exercise | 2018-11-12 | 2018-11-14 | 38,563 | $2.59 | $99.9K | 362,539 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2018-09-20 | 2018-09-21 | 427,265 | — | $0 | 427,265 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2018-08-10 | 2018-08-13 | 660 | $176.61 | $116.6K | 6,491 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2018-08-09 | 2018-08-13 | 3,735 | — | $0 | 3,735 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2018-08-09 | 2018-08-13 | 1,495 | — | $0 | 7,151 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 836,541 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 1,042,482 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 1,334,254 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 75,000 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 2,400 | $16.00 | $38.4K | 5,118 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 2,718 | — | $0 | 2,718 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 30,324 | — | $0 | 323,976 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 48,367 | — | $0 | 293,652 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 37,790 | — | $0 | 245,285 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2017-08-11 | 2017-08-14 | 3 | $144.13 | $432 | 5,656 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2017-08-11 | 2017-08-14 | 659 | $142.36 | $93.8K | 5,659 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2017-08-10 | 2017-08-14 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2017-08-10 | 2017-08-14 | 1,365 | — | $0 | 6,318 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 139,867 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 139,867 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 127,367 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2016-08-15 | 2016-08-17 | 633 | $136.45 | $86.4K | 4,953 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2016-08-11 | 2016-08-15 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2016-08-11 | 2016-08-15 | 1,365 | — | $0 | 5,586 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2016-05-16 | 2016-05-17 | 644 | $145.20 | $93.5K | 4,221 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2016-02-01 | 2016-02-03 | 12,500 | — | $0 | 121,859 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-08-10 | 2015-08-11 | 797 | $179.98 | $143.4K | 4,869 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-08-10 | 2015-08-11 | 4 | $183.36 | $733 | 4,865 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2015-08-07 | 2015-08-11 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2015-08-07 | 2015-08-11 | 1,310 | — | $0 | 5,666 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-05-12 | 2015-05-14 | 6 | $175.10 | $1.1K | 4,356 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-05-12 | 2015-05-14 | 644 | $173.85 | $112.0K | 4,362 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2015-01-31 | 2015-02-04 | 25,000 | $6.45 | $161.3K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2015-01-31 | 2015-02-04 | 12,500 | — | $0 | 109,359 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2014-08-07 | 2014-08-11 | 3,300 | — | $0 | 3,300 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2014-08-07 | 2014-08-11 | 1,650 | — | $0 | 5,006 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2014-05-28 | 2014-05-29 | 644 | $142.49 | $91.8K | 3,356 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2014-01-31 | 2014-02-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2014-01-31 | 2014-02-04 | 12,500 | — | $0 | 96,859 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2013-05-09 | 2013-05-13 | 8,000 | — | $0 | 8,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2013-05-09 | 2013-05-13 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2013-01-31 | 2013-02-04 | 14,000 | — | $0 | 84,359 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | A Award | 2013-01-16 | 2013-01-18 | 5,799 | — | $0 | 58,614 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | F Tax w/h | 2013-01-16 | 2013-01-18 | 1,925 | $66.52 | $128.1K | 56,689 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | M Exercise deriv | 2012-08-03 | 2012-08-06 | 70,125 | — | $0 | 0 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | S Sale | 2012-08-03 | 2012-08-06 | 70,125 | $58.99 | $4.14M | 52,815 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | M Exercise | 2012-08-03 | 2012-08-06 | 70,125 | $38.35 | $2.69M | 122,940 | SEC↗ |
| BAX BAXTER INTERNATIONAL INC | A Award deriv | 2012-03-06 | 2012-03-08 | 36,048 | — | $0 | 36,048 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2012-01-31 | 2012-01-31 | 18,359 | — | $0 | 70,359 | SEC↗ |